Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult

• Patient living at home or in an institution

• Patient hospitalized for less than 48 hours

• Pneumonia defined (according to the 2006 French-speaking infectious pneumology society (SPILF) criteria) by:

‣ respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and

⁃ Hyperthermia \>38,5°C or hypothermia \<36°C and

⁃ Radiological Signs of Pneumonia

• Hypoxia : SpO2 \< 94% in ambient air and/or PaO2\< 60 mmHg in ambient air

Locations
Other Locations
France
CHU Larrey
RECRUITING
Toulouse
Contact Information
Primary
Elise Noel-Savina, MD
noel-savina.e@chu-toulouse.fr
5 67 77 16 90
Time Frame
Start Date: 2018-03-09
Estimated Completion Date: 2028-10
Participants
Target number of participants: 128
Treatments
Other: Automated oxygen therapy
An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. Patients will receive O2 automated intervention.
Other: Standard Oxygen therapy
Patients will receive O2 standard therapy
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov